ID   Faza 967 clone 2
AC   CVCL_S739
SY   Faza 967clone2
DR   ChEMBL-Cells; CHEMBL3308588
DR   ChEMBL-Targets; CHEMBL614495
DR   PubChem_Cell_line; CVCL_S739
DR   Wikidata; Q54833254
RX   PubMed=2431944;
RX   PubMed=6617662;
CC   Selected for resistance to: ChEBI; CHEBI:41879; Dexamethasone.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS:0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_S742 ! DEX-Faza 967
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 13
//
RX   PubMed=2431944; DOI=10.1111/j.1432-0436.1986.tb00567.x;
RA   Venetianer A., Poliard A., Poiret M., Erdos T., Hermesz E.,
RA   Sala-Trepat J.M.;
RT   "Activation of alpha-fetoprotein synthesis in rat hepatoma cells with
RT   reduced sensitivity to dexamethasone.";
RL   Differentiation 32:148-156(1986).
//
RX   PubMed=6617662; DOI=10.1111/j.1432-1033.1983.tb07707.x;
RA   Bosze Z., Aranyi P., Venetianer A.;
RT   "Protein synthesis in differentiated and dedifferentiated hepatoma
RT   cell lines. Effect of glucocorticoids.";
RL   Eur. J. Biochem. 136:77-82(1983).
//